Patient Opportunity A LGOAX Fund Analysis

| Medalist Rating as of | See Patient Funds Investment Hub

Morningstar’s Analysis LGOAX

Will LGOAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A bold and volatile offering.

Associate Director Andrew Daniels

Andrew Daniels

Associate Director

Summary

Despite a relatively recent leadership transition, Patient Opportunity’s long-standing traits remain the same.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Sponsor Center